Non-muscle-invasive bladder cancer (NMIBC) is a heterogeneous disease with widely
different outcomes. We performed a comprehensive transcriptional analysis of 460 early-stage …

The molecular landscape in non-muscle-invasive bladder cancer (NMIBC) is characterized
by large biological heterogeneity with variable clinical outcomes. Here, we perform an …

Active vitamin D, 1,25-dihydroxyvitamin D 3 [1,25(OH) 2 D 3 ], plays a pivotal role in calcium
homeostasis and bone metabolism. Circulating levels of 1,25(OH) 2 D 3 are thought to be …

Purpose : Only 3% to 28% of patients referred to the urology clinic for hematuria are diagnosed
with bladder cancer. Cystoscopy leads to high diagnostic costs and a high patient burden…

Nonmuscle invasive tumors of the bladder often recur and thereby bladder cancer patients
need regular re‐examinations which are invasive, unpleasant, and expensive. A noninvasive …

Background Progression of non–muscle-invasive bladder cancer (NMIBC) to muscle-invasive
bladder cancer (MIBC) is life-threatening and cannot be accurately predicted using clinical …

Purpose: The European Association of Urology (EAU) guidelines for non–muscle-invasive
bladder cancer (NMIBC) recommend risk stratification based on clinicopathologic parameters. …

Objective We aimed to determine the validity of two risk scores for patients with non-muscle
invasive bladder cancer in different European settings, in patients with primary tumours. …

Bladder cancer is a common cancer with particularly high recurrence after transurethral
resection. In this study, we investigated the prognostic value of the protein expression of …

Biobanks of fresh, unfixed human tissue represent a valuable source for gene expression
analysis in translational research and molecular pathology. The aim of this study was to …